[go: up one dir, main page]

TN2013000429A1 - Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity - Google Patents

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

Info

Publication number
TN2013000429A1
TN2013000429A1 TNP2013000429A TN2013000429A TN2013000429A1 TN 2013000429 A1 TN2013000429 A1 TN 2013000429A1 TN P2013000429 A TNP2013000429 A TN P2013000429A TN 2013000429 A TN2013000429 A TN 2013000429A TN 2013000429 A1 TN2013000429 A1 TN 2013000429A1
Authority
TN
Tunisia
Prior art keywords
compounds
agonist activity
beta2 adrenergic
adrenergic receptor
receptor antagonist
Prior art date
Application number
TNP2013000429A
Other languages
English (en)
Inventor
Andrea Rizzi
Fabio Rancati
Gabriele Amari
Matteo Biagetti
Ian Linney
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/060795 external-priority patent/WO2012168359A1/fr
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of TN2013000429A1 publication Critical patent/TN2013000429A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNP2013000429A 2012-04-24 2013-10-18 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity TN2013000429A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12165283 2012-04-24
PCT/EP2012/060795 WO2012168359A1 (fr) 2011-06-10 2012-06-07 Composés ayant une activité antagoniste d'un récepteur muscarinique et agoniste d'un récepteur bêta2 adrénergique

Publications (1)

Publication Number Publication Date
TN2013000429A1 true TN2013000429A1 (en) 2015-03-30

Family

ID=54359586

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000429A TN2013000429A1 (en) 2012-04-24 2013-10-18 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

Country Status (1)

Country Link
TN (1) TN2013000429A1 (fr)

Similar Documents

Publication Publication Date Title
SG195375A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
PH12015501247A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
PH12017501424A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
BR112015012746A2 (pt) compostos que possuem atividade de antagonista de receptores muscarínicos e agonista de receptores beta2-adrenérgicos
EP4268814A3 (fr) Composition pharmaceutique pour le traitement de l'oeil sec
MX2012012897A (es) Nuevos derivados de ciclohexilamina que tienen actividad como agonistas adrenergicos beta-2 y como antagonistas muscarinicos m3.
HK1197240A1 (en) New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
PH12013501136A1 (en) Lysophosphatidic acid receptor antagonists and uses thereof
HUE039931T2 (hu) Szfingozin-1-foszfát receptor agonisták, azok elkészítési eljárásai, és azokat aktív ágensként tartalmazó gyógyszerészeti készítmények
PH12014501056A1 (en) New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
PH12015501398A1 (en) New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
MX376160B (es) Compuestos que tienen actividad antagonista del receptor muscarínico y actividad agonista del receptor beta2 adrenérgico.
TN2013000429A1 (en) Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
UA109581C2 (uk) Сполуки з активністю антагоністів мускаринових рецепторів і агоністів адренергічного рецептора бета2
UA96048C2 (ru) Применение антагониста рецепторов интерлейкина-1 как средства фригопротекторного действия